High frequency of MEFV gene mutations in patients with myeloid neoplasm

International Journal of Hematology

Volumn 91, Issue 5, 2010, Pages 758-761

  Oktenli, Cagatay ^a   Sayan, Ozkan ^a   Celik, Serkan ^a   Erikci, Alev A ^a   Tunca, Yusuf ^b   Terekeci, Hakan M ^a   Umur, Elcin Erkuvan ^a   Sanisoglu, Yavuz S ^c   Torun, Deniz ^b   Tangi, Fatih ^a   Sahan, Burak ^a   Nalbant, Selim ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c MINISTRY OF HEALTH   (Turkey)

Author keywords

Acute myeloid leukemia; Chronic myeloid leukemia; MEFV mutation; Myelodysplastic syndrome; Myeloid neoplasms; Polycythemia vera

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MALE; MEFV GENE; MYELODYSPLASTIC SYNDROME; POLYCYTHEMIA VERA; ACUTE MYELOBLASTIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; GENETICS; MIDDLE AGED; MUTATION; MYELOID LEUKEMIA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES; POLYCYTHEMIA VERA; YOUNG ADULT;

CYTOSKELETON PROTEIN; MARENOSTRIN;

EID: 77954541600     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0577-x     Document Type: Article

References (41)

1. U Musabak A Sengul C Oktenli S Pay Z Yesilova L Kenar, et al. 2004 Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol 138 526 533 10.1111/j.1365-2249.2004. 02632.x 1:CAS:528:DC%2BD2cXhtFGms7zP 15544632 (Pubitemid 39573635)
2. HM Terekeci C Oktenli T Ozgurtas S Nalbant C Top S Celik, et al. 2008 Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol 35 2024 2029 1:CAS:528:DC%2BD1cXhtlWit7bI 18785307
3. HM Terekeci ER Ulusoy NM Kucukarslan S Nalbant C Oktenli 2008 Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters Rheumatol Int 28 1239 1243 10.1007/s00296-008-0648-y 18648816
4. FMF The French 1997 Consortium: a candidate gene for familial Mediterranean fever Nat Genet 17 25 31 10.1038/ng0997-25 (Pubitemid 27377528)
5. FMF The International 1997 Consortium: ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever Cell 90 797 807 10.1016/S0092-8674(00)80539-5 (Pubitemid 27357970)
6. G Guz M Kanbay MA Ozturk 2009 Current perspectives on familial Mediterranean fever Curr Opin Infect Dis 22 309 315 10.1097/QCO.0b013e328329d15e 1:CAS:528:DC%2BD1MXltVykt7o%3D 19339884
7. I Touitou 2001 The spectrum of familial Mediterranean fever (FMF) mutations Eur J Hum Genet 9 473 483 10.1038/sj.ejhg.5200658 1:CAS:528: DC%2BD3MXmsVOlsbk%3D 11464238 (Pubitemid 32750487)
8. M Centola G Wood DM Frucht J Galon M Aringer C Farrell, et al. 2000 The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators Blood 95 3223 3231 1:CAS:528:DC%2BD3cXjt1Cjs7o%3D 10807793
9. G Grateau 2004 Clinical and genetic aspects of the hereditary periodic fever syndromes Rheumatology 43 410 415 10.1093/rheumatology/keh157 1:CAS:528:DC%2BD2cXitlyhsbY%3D 14983109 (Pubitemid 38489355)
10. B Koc C Oktenli F Bulucu N Karadurmus SY Sanisoglu D Gul 2007 The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study J Rheumatol 34 2070 2075 1:CAS:528: DC%2BD2sXht1ylurzE 17696266
11. C Stehlik JC Reed 2004 The PYRIN connection: novel players in innate immunity and inflammation J Exp Med 200 551 558 10.1084/jem.20032234 1:CAS:528:DC%2BD2cXns1SgtLc%3D 15353551 (Pubitemid 39258304)
12. JJ Chae HD Komarow J Cheng G Wood N Raben PP Liu, et al. 2003 Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis Mol Cell 11 591 604 10.1016/S1097-2765(03) 00056-X 1:CAS:528:DC%2BD3sXjtVWktrY%3D 12667444 (Pubitemid 36385116)
13. TA Dowds J Masumoto FF Chen Y Ogura N Inohara G Nunez 2003 Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product Biochem Biophys Res Commun 302 575 580 10.1016/S0006-291X(03)00221-3 1:CAS:528:DC%2BD3sXhs1Kgsrg%3D 12615073 (Pubitemid 36279569)
14. DL Gumucio A Diaz P Schaner N Richards C Babcock M Schaller, et al. 2002 Fire and ICE: the role of pyrin domain containing proteins in inflammation and apoptosis Clin Exp Rheumatol 20 S45 S53 1:STN:280:DC%2BD38nhsVKnsQ%3D%3D 12371636
15. GA Manji L Wang BJ Geddes M Brown S Merriam A Al-Garawi, et al. 2002 PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B J Biol Chem 277 11570 11575 10.1074/jbc.M112208200 1:CAS:528:DC%2BD38Xis1Kgt7w%3D 11786556 (Pubitemid 34952928)
16. C Stehlik M Krajewska K Welsh S Krajewski A Godzik JC Reed 2003 The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated NF-κB and pro-caspase-1 regulation Biochem J 373 101 113 10.1042/BJ20030304 1:CAS:528:DC%2BD3sXkvVent7k%3D 12656673 (Pubitemid 36819506)
17. C Stehlik L Fiorentino A Dorfleutner JM Bruey EM Ariza J Sagara, et al. 2002 The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways J Exp Med 196 1605 1615 10.1084/jem.20021552 1:CAS:528:DC%2BD38XpslWlu7w%3D 12486103 (Pubitemid 36026472)
18. A Keutgens I Robert P Viatour A Chariot 2006 Deregulated NF-kB activity in haematological malignancies Biochem Pharmacol 72 1069 1080 10.1016/j.bcp.2006.06.011 1:CAS:528:DC%2BD28XhtVagtr%2FP 16854381 (Pubitemid 44479739)
19. N Tidow X Chen C Muller S Kawano AF Gombart N Fischel-Ghodsian, et al. 2000 Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin Blood 95 1451 1455 1:CAS:528:DC%2BD3cXhtFKitb8%3D 10666224
20. K Sasaki T Tahara K Mitani 2009 Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome Int J Hematol 90 91 93 10.1007/s12185-009-0336-z 19466506
21. T Miyoshi K Yamashita T Ohno T Izumi A Takaori-Kondo M Sasada, et al. 2008 Familial Mediterranean fever gene as a possible modifier of sweet syndrome with chronic myelogenous leukemia Acta Haematol 120 57 62 10.1159/000158578 18824843
22. Y Kotone-Miyahara A Takaori-Kondo K Fukunaga M Goto Y Hayashino M Miki, et al. 2004 E148Q/M694I mutation in 3 Japanese patients with familial Mediterranean fever Int J Hematol 79 235 237 10.1532/IJH97.03119 1:CAS:528:DC%2BD2cXkvFCiurg%3D 15168590
23. E Demirkaya Y Tunca F Gok S Ozen D Gul 2008 A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients Clin Rheumatol 27 729 732 10.1007/s10067-007-0780-1 18000697
24. E Yilmaz S Ozen B Balci A Duzova R Topaloglu N Besbas, et al. 2001 Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population Eur J Hum Genet 9 553 555 10.1038/sj.ejhg.5200674 1:CAS:528:DC%2BD3MXmsVOltrs%3D 11464248 (Pubitemid 32750497)
25. RN Apte S Dotan M Elkabets MR White E Reich Y Carmi, et al. 2006 The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions Cancer Metastasis Rev 25 387 408 10.1007/s10555-006- 9004-4 1:CAS:528:DC%2BD28Xht1yktb3E 17043764 (Pubitemid 44922357)
26. RN Apte E Voronov 2008 Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol Rev 222 222 241 10.1111/j.1600-065X. 2008.00615.x 1:CAS:528:DC%2BD1cXlsFejt7o%3D 18364005 (Pubitemid 351430377)
27. D Cilloni G Martinelli F Messa M Baccarani G Saglio 2007 Nuclear factor κB as a target for new drug development in myeloid malignancies Haematologica 92 1124 1129 10.3324/haematol.11199 (Pubitemid 350144181)
28. S Ghosh MJ May EB Kopp 1998 NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune responses Annu Rev Immunol 16 225 260 10.1146/annurev.immunol.16.1.225 1:CAS:528:DyaK1cXislygtL0%3D 9597130 (Pubitemid 28183365)
29. SK Biswas L Gangi S Paul T Schioppa A Saccani M Sironi, et al. 2006 A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation) Blood 107 2112 2122 10.1182/blood-2005-01-0428 1:CAS:528:DC%2BD28XitFChtLc%3D 16269622 (Pubitemid 43289397)
30. DB Kerbauy HJ Deeg 2007 Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome Exp Hematol 35 1739 1746 10.1016/j.exphem.2007.09.007 1:CAS:528:DC%2BD2sXht1KrtLjN 17976524 (Pubitemid 47633781)
31. D Bouscary J De Vos M Guesnu K Jondeau F Viguier J Melle, et al. 1997 Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes Leukemia 11 839 845 10.1038/sj.leu.2400654 1:STN:280: DyaK2szitVGrtQ%3D%3D 9177438
32. DY Zang RG Goodwin MR Loken E Bryant HJ Deeg 2001 Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis Blood 98 3058 3065 10.1182/blood.V98.10.3058 1:CAS:528:DC%2BD3MXosFynt70%3D 11698291
33. DM Kerbauy V Lesnikov N Abbasi S Seal B Scott HJ Deeg 2005 NF-κB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs) Blood 106 3917 3925 10.1182/blood-2005-04-1424 1:CAS:528:DC%2BD2MXht12ktr%2FF 16105982 (Pubitemid 41739032)
34. T Braun G Carvalho C Fabre J Grosjean P Fenaux G Kroemer 2006 Targeting NF-κB in hematologic malignancies Cell Death Differ 13 748 758 10.1038/sj.cdd.4401874 1:CAS:528:DC%2BD28XjsFWisbc%3D 16498458
35. C Frelin V Imbert E Griessinger AC Peyron N Rochet P Philip, et al. 2005 Targeting NF-κB activation via pharmacologic inhibition of IKK2 induced apoptosis of human acute myeloid leukaemia cells Blood 105 804 811 10.1182/blood-2004-04-1463 1:CAS:528:DC%2BD2MXltlGmsA%3D%3D 15454494 (Pubitemid 40070768)
36. ML Guzman SJ Neering D Upchurch B Grimes DS Howard DA Rizzieri, et al. 2001 Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukaemia cells Blood 98 2301 2307 10.1182/blood.V98.8.2301 1:CAS:528:DC%2BD3MXnslCru74%3D 11588023
37. B Baumgartner M Weber M Quirling C Fischer S Page M Adam, et al. 2002 Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts Leukemia 16 2062 2071 10.1038/sj.leu.2402641 1:CAS:528:DC%2BD38XnsVams7o%3D 12357358 (Pubitemid 35203449)
38. CE Bueso-Ramos FC Rocha S Shishodia LJ Medeiros HM Kantarjian S Vadhan-Raj, et al. 2003 Expression of constitutively active nuclear-kB RelA transcription factor in blasts of acute myeloid leukaemia Hum Pathol 35 246 253 10.1016/j.humpath.2003.08.020
39. JY Reuther GW Reuther D Cortez AM Pendergast AS Baldwin Jr 1998 A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation Genes Dev 12 968 981 10.1101/gad.12.7.968 1:CAS:528:DyaK1cXisl2hurg%3D 9531535
40. D Kirchner J Duyster O Ottmann RM Schmid L Bergmann G Munzert 2003 Mechanisms of Bcr-Abl-mediated NF-kappB/Rel activation Exp Hematol 31 504 511 10.1016/S0301-472X(03)00069-9 1:CAS:528:DC%2BD3sXkvVKnsL0%3D 12829026 (Pubitemid 36793957)
41. G Grateau C Pecheux C Cazeneuve D Cattan M Dervichian M Goossens, et al. 2000 Clinical versus genetic diagnosis of familial Mediterranean fever Q J Med 93 223 229 1:STN:280:DC%2BD3M%2FhsVyhsw%3D%3D